Psychiatric Medications

  • Home
  • |
  • Psychiatric Medications

Psychiatric Medical Care- Medications & Supplements Guided by Genetic Analysis

Diagnosis is established through the use of the Structured Clinical Interview for Diagnosis, or SCID, which is the most reliable and valid method of determining psychiatric diagnosis. A convergence of other data then supports the SCID in determining diagnosis, including a variety of psychometric instruments, as well as functional neuroimaging through the use of quantitative electroencephalography (qEEG).

Treatment recommendations often include medications, though a variety of non-medication based therapeutic modalities are also employed to provide the patient the highest level of support possible. In the work of recovery from psychiatric struggle. Personalized medication recommendations are based on pharmacogenetic testing, which provides critical information on the patient’s metabolism and neurobiological functioning. A range of nonmedication-based modalities are also available at Synchrony Brain Health. These include neuromodulatory technologies, such as dTMS and Alpha Stim, nutraceuticals (e.g. specific vitamins and minerals, Omega 3 supplementation, etc), exercise, sleep regulation, and yoga all of which help to restore healthy functioning and well-being.

More Information on PsychiatricMedication

Genomind White Paper, The Science Behind the Genecept Assay™

Genomind, Inc., 2200 rlenaissance Blvd., Suite 100, King of Prussia, PA, 19406,

Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder

RJT Mocking, I Harmsen, J Assies, MWJ Koeter, HG Ruhé and AH Schene, Translational Psychiatry (2016) 6, e756; doi:10.1038/tp.2016.29; published online 15 March 2016

Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses

Jerome Sarris, Ph.D., M.H.Sc., Jenifer Murphy, Ph.D., David Mischoulon, M.D., Ph.D., George I. Papakostas, M.D., Maurizio Fava, M.D., Michael Berk, M.D., Ph.D., Chee H. Ng, M.D. Am J Psychiatry, Volume 173 Issue 6, June 01, 2016, pp. 575-587

L-Methylfolate as Adjunctive Therapy for SSRI-Resistant Major Depression: Results of Two Randomized, Double-Blind, Parallel-Sequential Trials

George I. Papakostas, M.D., Richard C. Shelton, M.D., John M. Zajecka, M.D., Bijan Etemad, M.D., Karl Rickels, M.D., Alisabet Clain, M.S., Lee Baer, Ph.D., Elizabeth D. Dalton, B.A., Garret R. Sacco, B.A., David Schoenfeld, Ph.D., Michael Pencina, Ph.D., Allison Meisner, M.A., Teodoro Bottiglieri, Ph.D., Erik Nelson, M.D., David Mischoulon, M.D., Ph.D., Jonathan E. Alpert, M.D., Ph.D., James G. Barbee, M.D., Sidney Zisook, M.D., and Maurizio Fava, M.D.American Journal of Psychiatry December 2012, Vol. 169, No. 12, pp. 1267 – 1274